CORRESP Filing
LIFECORE BIOMEDICAL, INC. \DE\
Date: Sept. 26, 2025 · CIK: 0001005286 · Accession: 0001628280-25-042888
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-290460
Letter
Document Lifecore Biomedical, Inc. 3515 Lyman Boulevard Chaska, MN 55318 September 26, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-6010 Attention: Daniel Crawford Re: Lifecore Biomedical, Inc. Registration Statement on Form S-3 File No. 333-290460 To the addressee set forth above: In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the above-referenced Registration Statement on Form S-3 (File No. 333-290460) (the “Registration Statement”) of Lifecore Biomedical, Inc. We respectfully request that the Registration Statement become effective as of 4:00 p.m. Eastern Time on September 30, 2025 or as soon as practicable thereafter, or at such other time thereafter as our counsel, Latham & Watkins LLP, may request by telephone. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Latham & Watkins LLP, by calling Darren Guttenberg at (714) 755-8050 or, in his absence, J. Ross McAloon at (714) 755-8051. Thank you for your assistance in this matter. Sincerely, LIFECORE BIOMEDICAL, INC. By: /s/ Tom Salus Tom Salus Chief Legal and Administration Officer cc: Paul Josephs, Lifecore Biomedical, Inc. Ryan D. Lake, Lifecore Biomedical, Inc. Darren Guttenberg, Latham & Watkins LLP J. Ross McAloon, Latham & Watkins LLP
Show Raw Text
CORRESP 1 filename1.htm Document Lifecore Biomedical, Inc. 3515 Lyman Boulevard Chaska, MN 55318 September 26, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-6010 Attention: Daniel Crawford Re: Lifecore Biomedical, Inc. Registration Statement on Form S-3 File No. 333-290460 To the addressee set forth above: In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the above-referenced Registration Statement on Form S-3 (File No. 333-290460) (the “Registration Statement”) of Lifecore Biomedical, Inc. We respectfully request that the Registration Statement become effective as of 4:00 p.m. Eastern Time on September 30, 2025 or as soon as practicable thereafter, or at such other time thereafter as our counsel, Latham & Watkins LLP, may request by telephone. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Latham & Watkins LLP, by calling Darren Guttenberg at (714) 755-8050 or, in his absence, J. Ross McAloon at (714) 755-8051. Thank you for your assistance in this matter. Sincerely, LIFECORE BIOMEDICAL, INC. By: /s/ Tom Salus Tom Salus Chief Legal and Administration Officer cc: Paul Josephs, Lifecore Biomedical, Inc. Ryan D. Lake, Lifecore Biomedical, Inc. Darren Guttenberg, Latham & Watkins LLP J. Ross McAloon, Latham & Watkins LLP